Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 1 16Phase 3 12Phase NA 8Phase 1/2 6Phase 2/3 5Phase EARLY_PHASE1 2

Status

Unknown 2Terminated 2Recruiting 2Completed 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 15Glioblastoma 14Neoplasms 12Brain Neoplasms 12Melanoma 11Pancreatic Neoplasms 10Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Prostatic Neoplasms 8Glioma 8Ovarian Neoplasms 7Neoplasm Metastasis 7Lymphoma 6Colonic Neoplasms 6Multiple Myeloma 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Stomach Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Acute 3

Interventions

RXDX-106 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Carcinoma, Squamous Cell × Clear all
NCT01755650 2023-09-13

Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies

Peter MacCallum Cancer Centre, Australia

Phase EARLY_PHASE1 Terminated
6 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

NCT03454243 2019-04-25

TITAN

Hoffmann-La Roche

Phase EARLY_PHASE1 Terminated
1 enrolled
DermatologicGenitourinaryLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Hodgkin Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡